While Mounjaro has secured FDA approval and insurance coverage, the same cannot be said for Tirzepatide as an independent compound. As of now, Tirzepatide is not covered by insurance. This lack of coverage can pose a financial challenge for patients who could potentially benefit from this medication. The reason behind this is that insurance companies typically require FDA approval before they cover a medication. Since Tirzepatide has not yet received this approval as a standalone treatment, it remains outside the scope of insurance coverage.